Business Description
ISIN : US2854091087
Total Employee Number:
180Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.82 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 14.69 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 48 | |||||
3-Year EPS without NRI Growth Rate | 53.4 | |||||
3-Year Book Growth Rate | 13.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.05 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.59 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.8 | |||||
9-Day RSI | 21.2 | |||||
14-Day RSI | 23.73 | |||||
3-1 Month Momentum % | 14.81 | |||||
6-1 Month Momentum % | 73.57 | |||||
12-1 Month Momentum % | 69.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.69 | |||||
Quick Ratio | 4.39 | |||||
Cash Ratio | 1.67 | |||||
Days Inventory | 80.7 | |||||
Days Sales Outstanding | 132.33 | |||||
Days Payable | 61.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 1.67 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.54 | |||||
Operating Margin % | 18.82 | |||||
Net Margin % | 15.32 | |||||
EBITDA Margin % | 20.27 | |||||
FCF Margin % | 11.34 | |||||
OCF Margin % | 13.1 | |||||
ROE % | 23.89 | |||||
ROA % | 19.62 | |||||
ROIC % | 29.15 | |||||
3-Year ROIIC % | 115.19 | |||||
ROC (Joel Greenblatt) % | 53.41 | |||||
ROCE % | 29.28 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.37 | |||||
Forward PE Ratio | 19.24 | |||||
PE Ratio without NRI | 21.37 | |||||
Shiller PE Ratio | 51.29 | |||||
Price-to-Owner-Earnings | 43.01 | |||||
PEG Ratio | 0.6 | |||||
PS Ratio | 3.3 | |||||
PB Ratio | 4.34 | |||||
Price-to-Tangible-Book | 4.47 | |||||
Price-to-Free-Cash-Flow | 29.08 | |||||
Price-to-Operating-Cash-Flow | 25.18 | |||||
EV-to-EBIT | 15.4 | |||||
EV-to-EBITDA | 14.29 | |||||
EV-to-Forward-EBITDA | 10.42 | |||||
EV-to-Revenue | 2.9 | |||||
EV-to-Forward-Revenue | 2.49 | |||||
EV-to-FCF | 25.56 | |||||
Price-to-GF-Value | 1.02 | |||||
Price-to-Projected-FCF | 2.17 | |||||
Price-to-Median-PS-Value | 1.37 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.85 | |||||
Price-to-Graham-Number | 2.06 | |||||
| Price-to-Net-Current-Asset-Value | 5.19 | |||||
| Price-to-Net-Cash | 28.57 | |||||
Earnings Yield (Greenblatt) % | 6.49 | |||||
FCF Yield % | 3.57 | |||||
Forward Rate of Return (Yacktman) % | 22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:ELMD
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Electromed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 73.776 | ||
| EPS (TTM) ($) | 1.31 | ||
| Beta | 1.32 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 1.53 | ||
| Volatility % | 65.9 | ||
| 14-Day RSI | 23.73 | ||
| 14-Day ATR ($) | 1.97316 | ||
| 20-Day SMA ($) | 36.162 | ||
| 12-1 Month Momentum % | 69.25 | ||
| 52-Week Range ($) | 23.01 - 47.4 | ||
| Shares Outstanding (Mil) | 8.37 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Electromed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Electromed Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2027-02-10 17:00 | In 156 days | ||
| Second quarter earnings results for 2027 | 2027-02-10 | In 155 days | ||
| General meeting for 2026 | 2026-11-13 08:00 | In 67 days | ||
| First quarter earnings conference call for 2027 | 2026-11-12 17:00 | In 66 days | ||
| First quarter earnings results for 2027 | 2026-11-12 | In 65 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-25 17:00 | 40.29 (+0.65%) | ||
| Annual report for 2026 | 2026-08-25 | 40.29 (+0.65%) | ||
| Fourth quarter earnings results for 2026 | 2026-08-25 | 40.29 (+0.65%) | ||
| Third quarter earnings conference call for 2026 | 2026-05-12 17:00 | 25.93 (-4.00%) | ||
| Third quarter earnings results for 2026 | 2026-05-12 | 25.93 (-4.00%) |
Electromed Inc Frequently Asked Questions
Guru Commentaries on AMEX:ELMD
Electromed reported strong fiscal third quarter results in May, handily beating expectations on both revenue and net income. The Fund's investment in Electromed has benefited from the improving market conditions in the healthcare sector, which has seen a lift in regulatory overhang and increased M&A activity. This positions Electromed well for continued growth as small-cap companies are showing strong revenue and profit growth. The Fund recognizes Electromed as a significant contributor to its performance, reflecting confidence in its operational trends and market potential.
Electromed's stock declined despite a strong financial update in February, which was an unexpected reaction. This decline indicates a disconnect between the company's performance and investor sentiment. The Fund has added to its position on this weakness, suggesting a belief in the long-term value of the company despite current market challenges. The leadership change and the company's position at an all-time low with minimal investor expectations present a potential opportunity for recovery.
Electromed is one of the top five holdings in the fund, but no specific argument or directional stance is provided regarding its future performance or valuation.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025 | 2025-06-09 | ||
| Sidoti Virtual Microcap Investor Conference | 2020-11-19 |
Articles on Electromed Inc
Headlines
See More- 1
- 1


